Incorporating demographic-specific left ventricular posterior wall thickness into computational cardiomyocyte models improves the assessment of inter-individual variability in drug-induced pro-arrhythmic risk.
Answers are grounded in this paper and cite their sources.
Enhances QTcF variability estimates in computational models; leaves open translation to human proarrhythmic risk assessment.
Correlation of the thickness of the left ventricular posterior wall (LVPWd) with various parameters, including age, gender, weight and height, was investigated in this study using regression models. Multicenter derived database comprised over 4,000 healthy individuals. The developed models were further utilized in the in vitro-in vivo (IVIV) translation of the drug cardiac safety data with use of the mathematical model of human cardiomyocytes operating at the virtual healthy population level. LVPWd was assumed to be equivalent to the length of one-dimensional string of virtual cardiomyocyte cells which was presented, as other physiological factors, to be a parameter influencing the simulated pseudo-ECG (pseudoelectrocardiogram), QTcF and ∆QTcF, both native and modified by exemplar drug (disopyramide) after I Kr current disruption. Simulation results support positive correlation between the LVPWd and QTcF/∆QTc. Developed models allow more detailed description of the virtual population and thus inter-individual variability influence on the drug cardiac safety.
No takes yet. Share an insight, caveat, or question.
Fijorek et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: